Able Laboratories Inc.
http://www.ablelabs.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Able Laboratories Inc.
Sun Starts Integration Of GSK's Opiates Business
Sun Pharmaceutical Industries has started the integration of its opiates business in Australia, acquired earlier this year from GlaxoSmithKline, following the completion of the deal.
Sun builds controlled substances play with GSK opiates buy
Sun Pharmaceutical Industries has acquired GlaxoSmithKline's opiates business in Australia – a move that is expected to help the Indian firm build significantly on its interests in the controlled substances space.
Yaupon Therapeutics Inc.
With a comparatively small amount of private equity capital raised to date, specialty pharma Yaupon Therapeutics Inc. has quickly managed to establish a four-compound pipeline and to move two of its candidates-one a drug for methamphetamine addiction, the other a topical agent for cutaneous T-cell lymphoma--into the clinic.
Orthopedic Opportunities
Managed care has sent orthopedics companies searching for new ways to lower or justify the costs of bone-repair and replacement. Surgeons have lost the freedom to select favorite products and now look to the bottom line. Companies are trying to use molecular biology and materials advances to develop products that will look and act like natural bone, and so produce better, longer-lasting healing. Yet safety and liability concerns, and memories of past disappointments, are keeping financiers skeptical.
Company Information
- Industry
- Services
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice